The study suggested that urine bFGF could be useful as a diagnostic tumour marker, allowing for distinction between dogs with UTI and dogs with TCC, or as a non-invasive indicator of treatment response [73]. This evidence concerns the gene FGF2 and bacterial urinary tract infection.